<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - AFFX</title>
<description>International Business News - AFFX</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Affymetrix to pay $73M for privately held Panomics</title>
  <description>Affymetrix Inc., which makes equipment for genetic data analysis, said Tuesday it will pay $73 million to acquire privately held Panomics. Affymetrix said the purchase would broaden its genetic and cellular analysis offerings.</description>
    <link>http://www.ibtimes.com/articles/20081111/affymetrix-to-pay-73m-for-privately-held-panomics.htm</link> 
  <pubDate>Tue, 11 Nov 2008 12:32:17 EST</pubDate>
  </item>


  <item>
  <title>Earnings roundup: Affymetrix, ITT</title>
  <description>Among the earnings stories for Friday, Oct. 24, from AP Financial News: SANTA CLARA, Calif. (AP)--Genetic data analysis instrument maker Affymetrix Inc. said it swung to a loss in the third quarter, as sales dropped and costs increased, and the company paid large restructuring costs.</description>
    <link>http://www.ibtimes.com/articles/20081024/earnings-roundup-affymetrix-itt.htm</link> 
  <pubDate>Fri, 24 Oct 2008 14:57:42 EDT</pubDate>
  </item>


  <item>
  <title>Costs and lower sales push Affymetrix to 3Q loss</title>
  <description>Genetic data analysis instrument maker Affymetrix Inc. said it swung to a loss in the third quarter, as sales dropped and costs increased, and the company paid large restructuring costs.</description>
    <link>http://www.ibtimes.com/articles/20081024/costs-and-lower-sales-push-affymetrix-to-3q-loss.htm</link> 
  <pubDate>Fri, 24 Oct 2008 11:51:42 EDT</pubDate>
  </item>


  <item>
  <title>Outlook roundup: Alphatec, Travelers</title>
  <description>Among the earnings projection stories for Monday, Oct. 13, from AP Financial News: CARLSBAD, Calif. (AP)--Medical device maker Alphatec Holdings Inc. on Monday raised its 2008 revenue guidance from $95 million to $100 million following strong third-quarter revenue growth.</description>
    <link>http://www.ibtimes.com/articles/20081013/outlook-roundup-alphatec-travelers.htm</link> 
  <pubDate>Mon, 13 Oct 2008 10:29:20 EDT</pubDate>
  </item>


  <item>
  <title>Affymetrix says 3Q revenue will miss forecasts</title>
  <description>Affymetrix Inc., which makes the GeneChip system for genetic data analysis, said Monday its third-quarter revenue fell below expectations because of increased competition and weak industrial spending.</description>
    <link>http://www.ibtimes.com/articles/20081013/affymetrix-says-3q-revenue-will-miss-forecasts.htm</link> 
  <pubDate>Mon, 13 Oct 2008 07:03:02 EDT</pubDate>
  </item>


  <item>
  <title>Illumina shares rise on genetic analyzer sales</title>
  <description>Shares of Illumina Inc. rose Thursday after the genetic analysis company said the Genome Institute of Singapore will add four of its gene analyzing systems to its operations.</description>
    <link>http://www.ibtimes.com/articles/20081009/illumina-shares-rise-on-genetic-analyzer-sales.htm</link> 
  <pubDate>Thu, 09 Oct 2008 11:17:17 EDT</pubDate>
  </item>


  <item>
  <title>Gene-testing startup's study responds to critics</title>
  <description>A Silicon Valley gene-testing startup is responding to criticism that the tests could spur bad health-care choices by teaming up for a broad study of how the results affect behavior.</description>
    <link>http://www.ibtimes.com/articles/20081009/gene-testing-startups-study-responds-to-critics.htm</link> 
  <pubDate>Thu, 09 Oct 2008 00:01:36 EDT</pubDate>
  </item>


  <item>
  <title>Affymetrix licenses genetic analysis technology</title>
  <description>Affymetrix Inc., which makes the GeneChip system for genetic data analysis, said Wednesday it licensed technology to Denmark-based Medical Prognosis Institute for an undisclosed amount.</description>
    <link>http://www.ibtimes.com/articles/20081001/affymetrix-licenses-genetic-analysis-technology.htm</link> 
  <pubDate>Wed, 01 Oct 2008 11:01:26 EDT</pubDate>
  </item>


  <item>
  <title>Affymetrix shares jump on cancer test approval</title>
  <description>Shares of Affymetrix Inc., which makes the GeneChip system for genetic data analysis, jumped Thursday after the Food and Drug Administration approved a new cancer testing system.</description>
    <link>http://www.ibtimes.com/articles/20080731/affymetrix-shares-jump-on-cancer-test-approval.htm</link> 
  <pubDate>Thu, 31 Jul 2008 11:14:23 EDT</pubDate>
  </item>


  <item>
  <title>Affymetrix shares dive to new low on 2Q results</title>
  <description>Shares of Affymetrix Inc. plunged Friday after the company's second-quarter loss widened on lower revenue and the genetic analysis company cut its full-year outlook on a forecast for weaker sales to pharmaceutical companies.</description>
    <link>http://www.ibtimes.com/articles/20080725/affymetrix-shares-dive-to-new-low-on-2q-results.htm</link> 
  <pubDate>Fri, 25 Jul 2008 13:47:41 EDT</pubDate>
  </item>


  <item>
  <title>Affymetrix cuts full-year revenue outlook</title>
  <description>Affymetrix Inc., which makes the GeneChip system for genetic data analysis, cut its full-year revenue outlook because of weakness in its pharmaceutical business, sending shares in a nosedive during after-hours trading.</description>
    <link>http://www.ibtimes.com/articles/20080724/affymetrix-cuts-full-year-revenue-outlook.htm</link> 
  <pubDate>Thu, 24 Jul 2008 19:15:50 EDT</pubDate>
  </item>


  <item>
  <title>Affymetrix swings to 2Q loss on revenue decline</title>
  <description>Affymetrix Inc., which makes the GeneChip system for genetic data analysis, said Thursday it swung to a second-quarter loss on lower revenue and a restructuring charge.</description>
    <link>http://www.ibtimes.com/articles/20080724/affymetrix-swings-to-2q-loss-on-revenue-decline.htm</link> 
  <pubDate>Thu, 24 Jul 2008 19:14:07 EDT</pubDate>
  </item>


  <item>
  <title>Sector Wrap: Life Sciences</title>
  <description>Shares of Illumina Inc. and Edwards Lifesciences hit new 52-week highs Wednesday, as a Cowen &amp; Co. analyst said a potential increase in the National Institute of Health&amp;#39;s fiscal 2009 budget would be a boon for life science tools makers.</description>
    <link>http://www.ibtimes.com/articles/20080625/sector-wrap-life-sciences.htm</link> 
  <pubDate>Wed, 25 Jun 2008 15:55:52 EDT</pubDate>
  </item>


  <item>
  <title>Market Spotlight: Life Sciences</title>
  <description>Invitrogen Corp.&amp;#39;s recent $6.4 billion deal to buy Applied Biosystems Group has ramped up speculation about further consolidation in the life sciences sector, as companies vie for larger market share.</description>
    <link>http://www.ibtimes.com/articles/20080619/market-spotlight-life-sciences.htm</link> 
  <pubDate>Thu, 19 Jun 2008 13:47:55 EDT</pubDate>
  </item>


  <item>
  <title>Sector Snap: Invitrogen deal lifts life sciences</title>
  <description>Invitrogen Corp.&amp;#39;s planned $6.4 billion buyout of Applera&amp;#39;s Applied Biosystems Group shone a spotlight on the wider life sciences product industry Thursday, boosting investor interest and share prices.</description>
    <link>http://www.ibtimes.com/articles/20080612/sector-snap-invitrogen-deal-lifts-life-sciences.htm</link> 
  <pubDate>Thu, 12 Jun 2008 15:21:14 EDT</pubDate>
  </item>


</channel>
</rss>